Tonghua Golden-Horse Pharma and Golden Meditech Holdings -- will submit bids in the second round of an auction to acquire I-MED Radiology.
Two China healthcare companies -- Tonghua Golden-Horse Pharma and Golden Meditech Holdings -- will submit bids in the second round of an auction to acquire I-MED Radiology, an Australian diagnostics service company. The bidding is expected to top $765 million. With nearly 200 clinics across Australia, I-MED is the nation’s largest diagnostic imaging services provider with 18% of the market. In 2016, I-MED reported $467 million in sales and $77 million in EBITDA.
